GENOVA, Inc. (TYO:9341)
Japan
· Delayed Price · Currency is JPY | Market Cap | 12.39B |
| Revenue (ttm) | 10.01B |
| Net Income (ttm) | 1.41B |
| Shares Out | 17.31M |
| EPS (ttm) | 79.02 |
| PE Ratio | 9.06 |
| Forward PE | n/a |
| Dividend | 10.00 (1.38%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 64,800 |
| Average Volume | 101,900 |
| Open | 718.00 |
| Previous Close | 716.00 |
| Day's Range | 714.00 - 722.00 |
| 52-Week Range | 705.00 - 1,975.00 |
| Beta | -0.64 |
| RSI | 37.61 |
| Earnings Date | Aug 8, 2025 |
About GENOVA
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay mac... [Read more]
Financial Performance
In 2024, GENOVA's revenue was 10.01 billion, an increase of 15.24% compared to the previous year's 8.68 billion. Earnings were 1.41 billion, a decrease of -18.13%.
Financial StatementsNews
Check Your Pantry ASAP for This Recalled Canned Tuna Brand
Tri-Union Seafoods announced a recall of canned tuna sold under the Trader Joe's, Genova, Van Camp's and H-E-B brand names due to quality and safety concerns.